Senior insider sale
SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$228.9K
5.37K shares
What this filing means
SENSENIG BETHANY plans to sell 5.37K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $228.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2025ACC: 0001950047-25-005825
Director
Since Feb 2026
5.37K
Shares to sell
$228.9K
Approx. market value
5.37K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/22/2025
5.37KTotal acquired5.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2025 | Restricted Stock Units N/A | 5.37K | — |
| Total | 5.37K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.37K
Market value
$228.9K
8/14/2025
Total
Units
5.37K
Value
$228.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2025 | 5.37K | $228.9K | NASDAQ | Planned |
| Total | 5.37K | $228.9K | ||